Dr. David Hoganson

Cardiac Pediatric Surgeon | Boston Children’s Hospital

Following my training, I joined the staff at Boston Children’s Hospital. My clinical focus is on neonates and children with congenital heart disease. I partner with Dr. Fynn-Thompson in the cardiac assist device and heart and lung transplant programs. Additionally I work as an intensivist in the cardiac intensive care unit. My research is focused on utilizing autologous umbilical veins as a shunt or patch material in neonates with complex congenital heart disease requiring surgery. My lab also focuses on development of devices to improve the safety and effectiveness of cardiac surgery, developing new transplant therapies and lung tissue engineering efforts to improve ECMO and oxygenator technologies.

All Sessions by Dr. David Hoganson

  • May 1, 2024

    Wednesday

  • 11:30 AM  - 12:15 PM
    In tandem with AI, the transformative potential of computational modeling and simulation is set to revolutionize clinical trials, providing a compelling vision of how these advanced digital technologies can minimize risks, cut costs, and expedite the product approval process.

    Medical device development has already employed modeling and simulation for product development and early-stage product testing. The latest advances now allow for continued operations in virtual environments throughout the clinical trial stage. This includes generating virtual patient cohorts for treatment arms and synthetic patients for control arms, offering an innovative approach to trial design, and streamlining the assessment of novel treatments.

    This session will explore the convergence of these technologies and present compelling evidence of progress, including recent collaborative efforts with the FDA in developing a groundbreaking blueprint for utilizing these advanced approaches, representing a significant step towards a more efficient and patient-centric future in device development.

    Sponsored By
    New Product Development
    Where
    161




Share

Dr. David Hoganson